Loading clinical trials...
Loading clinical trials...
A Multicenter, Open-label, Parallel Group Investigation to Compare the Performance of Standard Of Care (SOC) and Episil® in Combination Versus SOC Alone on Oral Mucositis in Patients Receiving Conditioning Treatment for Hematopoietic Stem Cell Transplantation
Conditions
Interventions
episil(R)
Oral hygiene procedures
Locations
12
Germany
Med Klinik und Poliklinik I Universitatsklinikum Carl Gustav Carus
Dresden, Germany
Abteilung fur Hamatologie und Onkologie Universitatsmedizin an der Georg-August-Universitat
Göttingen, Germany
Rambam Health Care Campus
Haifa, Israel
Hadassah Medical Centre
Jerusalem, Israel
Rabin Medical Center
Petah Tikva, Israel
The Tel-Aviv Sourasky Medical Centre
Tel Aviv, Israel
Start Date
February 1, 2013
Primary Completion Date
September 1, 2013
Completion Date
September 1, 2013
Last Updated
March 14, 2016
NCT05853692
NCT07040969
NCT06968520
NCT06390176
NCT07467759
NCT07287826
Lead Sponsor
Camurus AB
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions